Kineret Injection, Solution
Product Images NDC 66658-234

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Kineret (NDC 66658-234). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Swedish Orphan Biovitrum Ab (publ), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Kin10 0019 01

An instructional illustration showing items needed for subcutaneous injection of Kineret. It depicts a pre-filled syringe labeled Kineret 100 mg, an alcohol wipe packet, and a sterile gauze or tissue. These items are presented as necessary equipment for administering the injection.*

FDA Label Image

Kin10 0019 02

Kineret (anakinra) injection 100 mg/0.67 mL, subcutaneous solution. The label includes directions to discard any unused portion, states subcutaneous use only, and provides spaces for lot number and expiration date. The labeler is Swedish Orphan Biovitrum AB (publ), with NDC 66658-234-01.*

FDA Label Image

Kin10 0019 03

An instructional diagram showing a person holding a syringe labeled with parts including the syringe barrel, needle, and needle shield (cover). The image demonstrates how to handle the syringe prior to injection.*

FDA Label Image

Kin10 0019 04

An instructional illustration depicting a hand holding a syringe with the thumb pushing the plunger. The syringe is shown being held upright with an arrow indicating the direction of plunger movement. This likely demonstrates proper technique for handling the injection syringe.*

FDA Label Image

Kin10 0019 05

An instructional illustration showing a hand holding a syringe labeled Kineret, with the plunger being pressed to expel liquid onto a surface. A circular magnified inset highlights a portion of the syringe graduated scale, showing measurements around 40 to 80 units. This diagram visually explains the subcutaneous injection technique for Kineret (anakinra) solution.*

FDA Label Image

Kin10 0019 06

An instructional diagram illustrating recommended subcutaneous injection sites on a human body. The front view highlights the abdomen and front thighs, while the back view emphasizes the outer upper arms and buttocks as preferred injection areas.*

FDA Label Image

Kin10 0019 07

An illustration showing the front and back views of a child's body with shaded areas indicating injection sites for subcutaneous administration. Highlighted zones include the abdomen, the front thighs, and the upper outer arms. Labeled 'Front' and 'Back' for clear orientation.*

FDA Label Image

Kin10 0019 08

An instructional diagram showing the correct angles for administering a subcutaneous injection. One syringe is angled at 45 degrees and another at 90 degrees, both injecting into the thigh area of a seated person.*

FDA Label Image

Kin10 0019 09

An instructional illustration showing a hand holding a syringe with a needle approaching the skin of another hand for a subcutaneous injection. The needle is labeled in the image.*

FDA Label Image

Kin10 0019 10

A line drawing illustration showing a hand holding a syringe to a fingertip, with a label pointing to the needle. The image likely demonstrates a subcutaneous injection technique or finger-prick procedure.*

FDA Label Image

Kin10 0019 11

Illustration showing a hand pressing down on a small square gauze pad, likely demonstrating application or pressure after subcutaneous injection for Kineret (anakinra) injection, solution.*

FDA Label Image

Kin10 0019 12

Packaging label for Kineret (anakinra) injection, solution, 100 mg/0.67 mL, intended for subcutaneous use. The label indicates single use with discard of any unused portion, includes storage instructions to keep refrigerated, and mentions graduated prefilled glass syringes with 29 gauge needles. The labeler is Swedish Orphan Biovitrum AB (publ). The package includes a chart for tracking injection sites by day. The product is identified as prescription only with NDC 66658-234.*

FDA Label Image

Kin10 0019 13

Packaging label for Kineret (anakinra) injection, 100 mg/0.67 mL, a subcutaneous solution supplied in graduated prefilled glass syringes with 29 gauge needles. The label states it is a sterile solution with no preservative, single-use, and includes storage instructions to keep refrigerated. The labeler is Swedish Orphan Biovitrum AB (publ).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.